Treatment of Acute Gouty Attack
For an acute gout attack, initiate treatment immediately with corticosteroids as first-line therapy (prednisolone 30-35 mg daily for 3-5 days), NSAIDs, or low-dose colchicine (1 mg loading dose followed by 0.5 mg one hour later), choosing based on contraindications and patient factors. 1, 2
First-Line Treatment Options
All three major therapeutic options are equally effective for acute gout flares, but selection depends on patient-specific factors:
Corticosteroids (Preferred First-Line)
- Prednisolone 30-35 mg daily for 3-5 days is as effective as NSAIDs but generally safer with fewer adverse effects 1, 2
- Consider as first-line in patients without contraindications due to superior safety profile and low cost 1
- Can be given orally or via intra-articular injection if single joint involved 2
- Contraindicated only in systemic fungal infections 1
NSAIDs
- Any NSAID is acceptable—no evidence that indomethacin is superior to naproxen or ibuprofen 1
- Must be given with proton pump inhibitor if gastrointestinal risk factors present 2
- Avoid in patients with:
Low-Dose Colchicine
- Dosing: 1 mg loading dose followed by 0.5 mg one hour later on day 1 2
- Must be initiated within 12 hours of symptom onset for optimal efficacy 2
- Low-dose regimen (1.8 mg total) is as effective as high-dose (4.8 mg) but with placebo-level safety profile 2, 3
- More expensive than corticosteroids or NSAIDs 1
- Absolute contraindications:
Critical Timing Considerations
Treat as early as possible—ideally within 12 hours of symptom onset 2. Educate patients to self-medicate at first warning symptoms using a "pill in the pocket" approach 2.
Combination Therapy
For severe polyarticular attacks, consider combining colchicine with either an NSAID or corticosteroid 2. This approach is supported when multiple joints are involved and symptoms are particularly severe.
Refractory Cases
If patients have frequent flares with contraindications to all three first-line options, IL-1 blockers (canakinumab 150 mg) should be considered 2, 4, 3. Moderate-quality evidence shows canakinumab is more effective than intramuscular triamcinolone 40 mg with comparable safety 3.
Common Pitfalls to Avoid
- Do NOT use high-dose colchicine—the traditional high-dose regimen has significantly more adverse effects without additional benefit 2, 3
- Do NOT assume indomethacin is superior—this is a myth without evidence support 1
- Do NOT delay treatment—efficacy decreases substantially after 12 hours 2
- Do NOT start or stop urate-lowering therapy during an acute attack unless already established 2
Algorithm for Drug Selection
- No contraindications present: Choose corticosteroids (safest, cheapest) 1
- Renal impairment (eGFR <30): Use corticosteroids; avoid NSAIDs and colchicine 2
- Heart failure/cirrhosis: Use corticosteroids or colchicine; avoid NSAIDs 1
- On CYP3A4 inhibitors or statins: Use corticosteroids or NSAIDs; avoid colchicine 2
- Diabetes/infection risk: Prefer NSAIDs or colchicine over corticosteroids
- Single joint involvement: Consider intra-articular corticosteroid injection 2
- Multiple contraindications: Consider IL-1 blocker (canakinumab) 2, 3